Carcinosinum 200C (Paramesh Banerji Life Sciences LLC)
Welcome to the PulseAid listing for the Carcinosinum 200C drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Paramesh Banerji Life Sciences LLC |
| NON-PROPRIETARY NAME: | Carcinosinum |
| SUBSTANCE NAME: | HUMAN BREAST TUMOR CELL |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2017-02-02 |
| END MARKETING DATE: | 0000-00-00 |
Carcinosinum 200C HUMAN OTC DRUG Details:
| Item Description | Carcinosinum 200C from Paramesh Banerji Life Sciences LLC |
| LABELER NAME: | Paramesh Banerji Life Sciences LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200([hp_C]/1) |
| START MARKETING DATE: | 2017-02-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69152-1114_1862b88d-066c-5635-e054-00144ff88e88 |
| PRODUCT NDC: | 69152-1114 |
| APPLICATION NUMBER: | |
Other HUMAN BREAST TUMOR CELL Pharmaceutical Manufacturers / Labelers:
